phone iconPhone: (401) 822-4673
phone iconFax: (401) 822-4676
Receive our Health e-Newsletter

News for Healthier Living

Patients with Atrial Fibrillation Face Higher Bleeding Risks When Treated with 2 Common Medications

Patients with atrial fibrillation who are prescribed diltiazem to control heart rate alongside anticoagulants (blood thinners) such as apixaban or rivaroxaban face a higher risk of serious bleeding compared with those taking metoprolol, according to a new study from Vanderbilt Health researchers and colleagues at the Perelman School of Medicine.

February 26, 2026


February 28 2026

February 27 2026

February 26 2026

February 25 2026

February 24 2026

February 23 2026

February 22 2026

February 21 2026

February 20 2026

February 19 2026

February 18 2026

February 17 2026

February 16 2026

February 15 2026

Angell Street Psychiatry
Copyright 2026 HealthBanks, Inc. All rights reserved.
Terms of Use | Privacy Policy